Irvine, CA, United States of America

Frank L Meyskens

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Frank L Meyskens: Innovator in Dermatological and Oncological Solutions

Introduction

Frank L Meyskens is a prominent inventor based in Irvine, CA (US), known for his significant contributions to dermatology and oncology. With a total of 8 patents, he has developed innovative solutions aimed at improving skin health and cancer treatment.

Latest Patents

Meyskens' latest patents include groundbreaking work on topical pterostilbene compositions designed to treat UV-induced loss of barrier function in skin. This invention provides a chemoprotective method that utilizes pterostilbene to prevent damage caused by ultraviolet (UV) light. Additionally, he has developed pharmaceutical and nutraceutical compositions containing pterostilbene, which are suitable for administration to individuals to prevent subsequent UV-mediated skin damage. Another notable patent focuses on carcinoma diagnosis and treatment based on the ODC1 genotype. This invention offers methods and kits for predicting colorectal cancer patient survival and selecting appropriate treatment options based on genetic markers.

Career Highlights

Throughout his career, Frank L Meyskens has worked with esteemed institutions such as the University of California and the University of Arizona. His research has significantly advanced the understanding of skin health and cancer treatment methodologies.

Collaborations

Meyskens has collaborated with notable colleagues, including Eugene W Gerner and Jason A Zell, contributing to the development of innovative solutions in his field.

Conclusion

Frank L Meyskens stands out as a key figure in the realms of dermatology and oncology, with a focus on innovative treatments that address critical health issues. His work continues to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…